Trial Outcomes & Findings for Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs (NCT NCT03695393)
NCT ID: NCT03695393
Last Updated: 2021-09-05
Results Overview
Number of participants with satisfaction score of ≥ 3 out of 5. Score determined by an average of a 3-item Likert scale (1-5) questionnaire, developed by the study team.
COMPLETED
NA
100 participants
1 month
2021-09-05
Participant Flow
Participant milestones
| Measure |
Intervention- Acceptance and Commitment Therapy (ACT)
Participants randomized to this group will receive three ACT sessions over 1 month
Acceptance and Commitment Therapy (ACT): The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Overall Study
STARTED
|
67
|
33
|
|
Overall Study
1-month
|
66
|
32
|
|
Overall Study
6-month
|
64
|
31
|
|
Overall Study
COMPLETED
|
64
|
31
|
|
Overall Study
NOT COMPLETED
|
3
|
2
|
Reasons for withdrawal
| Measure |
Intervention- Acceptance and Commitment Therapy (ACT)
Participants randomized to this group will receive three ACT sessions over 1 month
Acceptance and Commitment Therapy (ACT): The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Overall Study
Death
|
3
|
1
|
|
Overall Study
Lost to Follow-up
|
0
|
1
|
Baseline Characteristics
Stigma, Risk Behaviors and Health Care Among HIV-infected Russian People Who Inject Drugs
Baseline characteristics by cohort
| Measure |
Intervention- ACT Therapy
n=67 Participants
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
n=33 Participants
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
Total
n=100 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
67 Participants
n=5 Participants
|
33 Participants
n=7 Participants
|
100 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
38.28 years
STANDARD_DEVIATION 4.87 • n=5 Participants
|
37.67 years
STANDARD_DEVIATION 6.39 • n=7 Participants
|
38.08 years
STANDARD_DEVIATION 5.39 • n=5 Participants
|
|
Sex: Female, Male
Female
|
33 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
49 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
34 Participants
n=5 Participants
|
17 Participants
n=7 Participants
|
51 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
65 Participants
n=5 Participants
|
31 Participants
n=7 Participants
|
96 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Region of Enrollment
Russia
|
67 Participants
n=5 Participants
|
33 Participants
n=7 Participants
|
100 Participants
n=5 Participants
|
|
Education
Middle school or less
|
17 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
27 Participants
n=5 Participants
|
|
Education
High school/college
|
47 Participants
n=5 Participants
|
23 Participants
n=7 Participants
|
70 Participants
n=5 Participants
|
|
Education
Higher education
|
3 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Marital status
Married/domestic partnership
|
43 Participants
n=5 Participants
|
24 Participants
n=7 Participants
|
67 Participants
n=5 Participants
|
|
Marital status
Long-term relationship but not living together
|
4 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
|
Marital status
Single/Divorced/Widowed/Separated
|
20 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
27 Participants
n=5 Participants
|
|
HIV internalized stigma
|
3.31 Units on a scale
STANDARD_DEVIATION 1.78 • n=5 Participants
|
3.52 Units on a scale
STANDARD_DEVIATION 1.60 • n=7 Participants
|
3.38 Units on a scale
STANDARD_DEVIATION 1.72 • n=5 Participants
|
|
Substance use stigma
|
31.40 Units on a scale
STANDARD_DEVIATION 7.27 • n=5 Participants
|
32.45 Units on a scale
STANDARD_DEVIATION 7.35 • n=7 Participants
|
31.75 Units on a scale
STANDARD_DEVIATION 7.28 • n=5 Participants
|
PRIMARY outcome
Timeframe: 1 monthPopulation: Participants who completed the 1-month assessment and attended at least one session. 64 of the 66 intervention participants completed the 1-month assessment AND at least one intervention session.
Number of participants with satisfaction score of ≥ 3 out of 5. Score determined by an average of a 3-item Likert scale (1-5) questionnaire, developed by the study team.
Outcome measures
| Measure |
Intervention- ACT Therapy
n=64 Participants
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Number of Participants Satisfied With the Intervention
|
61 Participants
|
0 Participants
|
PRIMARY outcome
Timeframe: baseline, 1 monthPopulation: Participants who completed the 1-month assessment
Mean change in HIV internalized stigma score between baseline and 1 month. Measured via a modified HIV internalized stigma scale, a 7-item questionnaire. Each item had yes/no options. Scores ranged from 0 to 7. Higher scores correspond to higher HIV stigma.
Outcome measures
| Measure |
Intervention- ACT Therapy
n=66 Participants
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
n=32 Participants
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Change in HIV Stigma Score
|
0.45 units on a scale
Standard Deviation 1.42
|
-0.06 units on a scale
Standard Deviation 1.05
|
PRIMARY outcome
Timeframe: baseline, 1 MonthPopulation: Participants who completed the 1-month assessment
Mean change in substance use stigma score between baseline and 1 month. Measured via Modified Substance Abuse Self-Stigma Scale, an 12-item questionnaire. Each item was assessed on a 5-point Likert scale. Scores ranged from 12 to 60. Higher scores correspond to higher substance use stigma.
Outcome measures
| Measure |
Intervention- ACT Therapy
n=66 Participants
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
n=32 Participants
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Change in Substance Use Stigma
|
-1.42 Units on a scale
Standard Deviation 7.14
|
0.06 Units on a scale
Standard Deviation 7.81
|
SECONDARY outcome
Timeframe: Throughout the study to completion at 6 monthsPopulation: Only intervention arm participants analyzed for this outcome.
Defined as the number of participants who participated in three ACT intervention sessions
Outcome measures
| Measure |
Intervention- ACT Therapy
n=67 Participants
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Number of Participants Who Participated in the Intervention
|
54 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: Throughout the study to completion at 6 monthsPopulation: Each intervention session was divided into 3 segments, totaling to 9 segments over 3 sessions. The first segment was discarded, as it only included introductions and no intervention content. The total number of segments throughout the intervention was 104 (8 segments of 13 groups). 30% of these segments were randomly selected to code to assess for fidelity, which resulted in 33 segments coded. This outcome is assessing the intervention segments, not the participants.
Defined using the Adherence Raters' Manual for Stigma Treatment Study to rate the recorded intervention tapes. This outcome reports the number of intervention segments that meet adequate fidelity. Overall fidelity rated on a score of 1 (low) to 5 (high). Score of a 3 or above was considered adequate fidelity.
Outcome measures
| Measure |
Intervention- ACT Therapy
n=33 Intervention segments
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Overall Fidelity to Intervention
|
33 Intervention segments
|
0 Intervention segments
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: Participants who completed the 6-month assessment
Defined as self-report of antiretroviral therapy (ART) initiation in the past 6 months.
Outcome measures
| Measure |
Intervention- ACT Therapy
n=64 Participants
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
n=31 Participants
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Initiation of HIV Care
|
13 Participants
|
1 Participants
|
SECONDARY outcome
Timeframe: 6 monthsPopulation: Participants who completed the 6-month assessment
Defined as self-report of treatment of a substance use disorder in an outpatient clinic, inpatient setting, or attendance of 12-step recovery program in the past 6 months.
Outcome measures
| Measure |
Intervention- ACT Therapy
n=64 Participants
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
n=31 Participants
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Engagement in Substance Use Care
|
15 Participants
|
2 Participants
|
SECONDARY outcome
Timeframe: baseline, 6 monthsPopulation: Participants who completed the 6-month assessment
Defined as self-report of any change in injection drug use in the previous 30 days measured via a modified Risk Behavior Survey. Participants report total number of injections in the past 30 days.
Outcome measures
| Measure |
Intervention- ACT Therapy
n=64 Participants
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
n=31 Participants
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Change in the Total Number of Injections in the Previous 30 Days
|
-1.78 Number of injections
Standard Deviation 14.60
|
7.16 Number of injections
Standard Deviation 22.34
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 monthsMeasured via the Patient Health Questionnaire-9, a 9-item questionnaire with higher scores corresponding to greater depression severity.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 monthsMeasured via the Generalized Anxiety Disorder-7 scale, a 7-item questionnaire with higher scores corresponding to greater anxiety severity.
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 monthsMeasured by both substance use stigma and HIV stigma scales, with high scores on both indicating intersectional stigma
Outcome measures
Outcome data not reported
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 monthsMeasured via Acceptance and Action Questionnaire - Substance Abuse, an 18-item questionnaire. Higher scores correspond to higher psychological flexibility
Outcome measures
Outcome data not reported
Adverse Events
Intervention- ACT Therapy
Standard of Care
Serious adverse events
| Measure |
Intervention- ACT Therapy
n=67 participants at risk
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
n=33 participants at risk
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Immune system disorders
Hospitalization due to HIV progression
|
1.5%
1/67 • Number of events 1 • Adverse event data were collected over the course of the 6-month study period.
|
0.00%
0/33 • Adverse event data were collected over the course of the 6-month study period.
|
|
Infections and infestations
Hospitalization due to pulmonary tuberculosis
|
1.5%
1/67 • Number of events 1 • Adverse event data were collected over the course of the 6-month study period.
|
0.00%
0/33 • Adverse event data were collected over the course of the 6-month study period.
|
|
Nervous system disorders
Death due to stroke
|
0.00%
0/67 • Adverse event data were collected over the course of the 6-month study period.
|
3.0%
1/33 • Number of events 1 • Adverse event data were collected over the course of the 6-month study period.
|
|
Nervous system disorders
Death due to cerebral edema
|
3.0%
2/67 • Number of events 2 • Adverse event data were collected over the course of the 6-month study period.
|
0.00%
0/33 • Adverse event data were collected over the course of the 6-month study period.
|
|
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Death due to cancer
|
1.5%
1/67 • Number of events 1 • Adverse event data were collected over the course of the 6-month study period.
|
0.00%
0/33 • Adverse event data were collected over the course of the 6-month study period.
|
Other adverse events
| Measure |
Intervention- ACT Therapy
n=67 participants at risk
Participants randomized to this group will receive three ACT sessions over 1 month
ACT Therapy: The ACT intervention will consist of three 2-hour group sessions of culturally adapted ACT (intervention) to reduce stigma and related manifestations.Participants are recruited from a civil society organization and all other study procedures take place at a rehabilitation center. The ACT sessions will be scheduled to take place at the rehabilitation center following randomization.The First St. Petersburg Pavlov State Medical University is an alternative location where sessions can be conducted. Sessions will be planned to occur in weekly succession, with a goal of 3 sessions within the first month of study participation.
|
Standard of Care
n=33 participants at risk
Participants in the control group will receive standard care as normally provided to patients by civil society organizations.
|
|---|---|---|
|
Immune system disorders
HIV progression
|
1.5%
1/67 • Number of events 1 • Adverse event data were collected over the course of the 6-month study period.
|
0.00%
0/33 • Adverse event data were collected over the course of the 6-month study period.
|
|
Infections and infestations
Pulmonary tuberculosis
|
1.5%
1/67 • Number of events 1 • Adverse event data were collected over the course of the 6-month study period.
|
0.00%
0/33 • Adverse event data were collected over the course of the 6-month study period.
|
Additional Information
Karsten Lunze, MD
Boston Medical Center and BU School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place